Sandor L, Huh J, Benko P, Hiraga T, Poliska S, Dobo-Nagy C
Cell Rep. 2024; 43(3):113936.
PMID: 38489269
PMC: 10995766.
DOI: 10.1016/j.celrep.2024.113936.
Kudo W, Hashitani H
Pflugers Arch. 2024; 476(5):809-820.
PMID: 38421408
DOI: 10.1007/s00424-024-02931-2.
Xing H, Han R, Wang Q, Sun Z, Li H
Anim Biosci. 2024; 37(8):1367-1376.
PMID: 38419534
PMC: 11222856.
DOI: 10.5713/ab.23.0421.
Kaibuchi N, Akagi Y, Kagawa C, Shibayama C, Kawase-Koga Y, Okamoto T
Oral Maxillofac Surg. 2024; 28(3):1399-1404.
PMID: 38418701
DOI: 10.1007/s10006-024-01231-4.
Takahashi K, Ohyama H, Ohno I, Takiguchi Y, Kato N
Cureus. 2024; 16(1):e52951.
PMID: 38406045
PMC: 10894057.
DOI: 10.7759/cureus.52951.
Expressions of parathyroid hormone-related protein (PTHrP) and parathyroid hormone receptor-1 (PTH1R) in the condylar cartilage of temporomandibular joint modulated by occlusal elevation.
Zhuang Q, Li B, Wu X
J Dent Sci. 2023; 18(2):626-635.
PMID: 37021209
PMC: 10068374.
DOI: 10.1016/j.jds.2022.08.001.
Molecular and Clinical Spectrum of Primary Hyperparathyroidism.
Jha S, Simonds W
Endocr Rev. 2023; 44(5):779-818.
PMID: 36961765
PMC: 10502601.
DOI: 10.1210/endrev/bnad009.
Phosphate Homeostasis and Disorders of Phosphate Metabolism.
Perumal N, Padidela R
Curr Pediatr Rev. 2022; 20(4):412-425.
PMID: 36545737
DOI: 10.2174/1573396319666221221121350.
Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications.
Vilardaga J, Clark L, White A, Sutkeviciute I, Lee J, Bahar I
Endocr Rev. 2022; 44(3):474-491.
PMID: 36503956
PMC: 10461325.
DOI: 10.1210/endrev/bnac032.
Markers for internal neoplasia in the horse.
Drozdzewska K, Gehlen H
Vet Med Sci. 2022; 9(1):132-143.
PMID: 36495211
PMC: 9857019.
DOI: 10.1002/vms3.1042.
High Sensitivity Measurement of Parathyroid Hormone-Related Protein (PTHrP) in Plasma by LC-MS/MS.
Kushnir M, Rockwood A
Methods Mol Biol. 2022; 2546:375-389.
PMID: 36127605
DOI: 10.1007/978-1-0716-2565-1_33.
A New in Silico Antibody Similarity Measure Both Identifies Large Sets of Epitope Binders with Distinct CDRs and Accurately Predicts Off-Target Reactivity.
Musnier A, Bourquard T, Vallet A, Mathias L, Bruneau G, Ayoub M
Int J Mol Sci. 2022; 23(17).
PMID: 36077163
PMC: 9456297.
DOI: 10.3390/ijms23179765.
Cranial Base Synchondrosis: Chondrocytes at the Hub.
Hallett S, Ono W, Franceschi R, Ono N
Int J Mol Sci. 2022; 23(14).
PMID: 35887171
PMC: 9317907.
DOI: 10.3390/ijms23147817.
PTH1R Actions on Bone Using the cAMP/Protein Kinase A Pathway.
Martin T
Front Endocrinol (Lausanne). 2022; 12:833221.
PMID: 35126319
PMC: 8807523.
DOI: 10.3389/fendo.2021.833221.
RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice.
Pin F, Jones A, Huot J, Narasimhan A, Zimmers T, Bonewald L
J Bone Miner Res. 2021; 37(3):381-396.
PMID: 34904285
PMC: 8940654.
DOI: 10.1002/jbmr.4480.
Phosphate, Calcium, and Vitamin D: Key Regulators of Fetal and Placental Development in Mammals.
Stenhouse C, Suva L, Gaddy D, Wu G, Bazer F
Adv Exp Med Biol. 2021; 1354():77-107.
PMID: 34807438
DOI: 10.1007/978-3-030-85686-1_5.
Parathyroid Hormone 1 Receptor Signaling in Dental Mesenchymal Stem Cells: Basic and Clinical Implications.
Lyu P, Li B, Li P, Bi R, Cui C, Zhao Z
Front Cell Dev Biol. 2021; 9:654715.
PMID: 34760881
PMC: 8573197.
DOI: 10.3389/fcell.2021.654715.
Functional Duality of Chondrocyte Hypertrophy and Biomedical Application Trends in Osteoarthritis.
Park S, Bello A, Arai Y, Ahn J, Kim D, Cha K
Pharmaceutics. 2021; 13(8).
PMID: 34452101
PMC: 8400409.
DOI: 10.3390/pharmaceutics13081139.
The bromodomain inhibitor JQ1+ reduces calcium-sensing receptor activity in pituitary cell lines.
Lines K, Gluck A, Thongjuea S, Bountra C, Thakker R, Gorvin C
J Mol Endocrinol. 2021; 67(3):83-94.
PMID: 34223822
PMC: 8345903.
DOI: 10.1530/JME-21-0030.
From Good to Bad: The Opposing Effects of PTHrP on Tumor Growth, Dormancy, and Metastasis Throughout Cancer Progression.
Edwards C, Johnson R
Front Oncol. 2021; 11:644303.
PMID: 33828987
PMC: 8019909.
DOI: 10.3389/fonc.2021.644303.